Treatment of “Poor Risk” Acute Myeloid Leukemia with Fludarabine, Cytarabine and G-CSF (Flag Regimen): A Single Center Study-Reference-Cited by-同舟云学术

Treatment of “Poor Risk” Acute Myeloid Leukemia with Fludarabine, Cytarabine and G-CSF (Flag Regimen): A Single Center Study

Published:2001-01 Issue:3-4 Volume:40 Page:295-303
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Carella Angelo Michele,Cascavilla Nicola,Greco Michele Mario,Melillo Lorella,Sajeva Maria Rosaria,Ladogana Saverio,D'arena Giovanni,Perla Gianni,Carotenuto Mario

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190109057928

Reference29 articles.

1. Acute Myeloid Leukemia

2. Arabinosyl cytosine: a 20-year update.

3. High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia

4. High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML;Aging;2020-04-01

2. Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/ Refractory Acute Myeloid Leukemia;Clinical oncohematology;2019

3. How I treat older patients with acute myeloid leukemia;Cancer;2018-05-29

4. Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia;Leukemia & Lymphoma;2018-04-04

5. Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study;Indian Journal of Hematology and Blood Transfusion;2017-02-14